| Literature DB >> 23304171 |
L F Grimsley1, J Wildfire, M Lichtveld, S Kennedy, J M El-Dahr, P C Chulada, R Cohn, H Mitchell, E Thornton, M Mvula, Y Sterling, W Martin, K Stephens, L White.
Abstract
Mold and other allergen exposures exacerbate asthma symptoms in sensitized individuals. We evaluated allergen concentrations, skin test sensitivities, and asthma morbidity for 182 children, aged 4-12 years, with moderate to severe asthma, enrolled 18 months after Katrina, from the city of New Orleans and the surrounding parishes that were impacted by the storm, into the Head-off Environmental Asthma in Louisiana (HEAL) observational study. Dust (indoor) and air (indoor and outdoor) samples were collected at baseline of 6 and 12 months. Dust samples were evaluated for dust mite, cockroach, mouse, and Alternaria by immunoassay. Air samples were evaluated for airborne mold spore concentrations. Overall, 89% of the children tested positive to ≥1 indoor allergen, with allergen-specific sensitivities ranging from 18% to 67%. Allergen concentration was associated with skin sensitivity for 1 of 10 environmental triggers analyzed (cat). Asthma symptom days did not differ with skin test sensitivity, and surprisingly, increased symptoms were observed in children whose baseline indoor airborne mold concentrations were below median levels. This association was not observed in follow-up assessments. The lack of relationship among allergen levels (including mold), sensitivities, and asthma symptoms points to the complexity of attempting to assess these associations during rapidly changing social and environmental conditions.Entities:
Year: 2012 PMID: 23304171 PMCID: PMC3523147 DOI: 10.1155/2012/427358
Source DB: PubMed Journal: Int J Pediatr ISSN: 1687-9740
Baseline characteristics of the study population (N = 182).
| Demographics | |
|---|---|
| Male | 98/182 (54%) |
| Race/ethnicity | |
| African-American | 122/182 (67%) |
| Caucasian | 48/182 (26%) |
| Hispanic | 12/182 (7%) |
| Household income < $15,000 | 43/170 (25%) |
| At least one smoker in the household | 58/182 (32%) |
| Caretaker married | 97/182 (54%) |
| Caretaker completed high school | 159/182 (88%) |
|
| |
| Housing | |
|
| |
| Baseline home is same as home pre-Katrina | 92/182 (51%) |
| Moved at least once between Katrina and baseline | 171/182 (94%) |
| Moved at least once during the study | 37/182 (20%) |
| Baseline home flooded | 68/182 (37%) |
| Completed home renovations at baseline | 85/182 (47%) |
| Renovations ongoing at baseline | 38/182 (21%) |
|
| |
| Baseline asthma symptoms in the previous 2 weeks | |
|
| |
| Maximum symptom days | 6.6 ± 4.9 |
| Daytime symptoms | 5.3 ± 4.5 |
| Night symptoms | 3.3 ± 4.2 |
| Slow play | 3.2 ± 3.9 |
| Caretaker changed plans | 0.9 ± 1.7 |
|
| |
| Allergen sensitivities | |
|
| |
| Skin tests (≥3 mm wheal) | |
| Der f/der p mix | 121/180 (67%) |
| Cat | 64/180 (36%) |
| Cockroach mix | 93/180 (52%) |
| Dog | 51/180 (28%) |
| Rat | 33/180 (18%) |
| Mouse | 54/180 (30%) |
|
| 52/180 (29%) |
|
| 43/180 (24%) |
|
| 86/180 (48%) |
|
| 96/180 (53%) |
| Number of mold sensitivities (14 total molds tested) | 5.3 ± 5.1 |
|
| |
| Household allergens | |
|
| |
|
| |
| Detectable | 178/181 (98%) |
| >10 | 105/181 (58%) |
| Cockroach (Bla g 1) | |
| Detectable | 37/181 (20%) |
| >2 U/g | 8/181 (4%) |
| Dust mite (Der p 1) | |
| Detectable | 63/181 (35%) |
| >2 | 16/181 (9%) |
| Mouse (Mus m 1) | |
| Detectable | 108/181 (60%) |
| >1.6 | 5/181 (3%) |
| Microbial component | |
|
| 0.50 ± 0.06 |
| Endotoxin (EU/mg) | 11.4 ± 1.5 |
| Self-report of pet ownership | |
| Dog | 46/182 (25%) |
| Cat | 16/182 (9%) |
|
| |
| Mold air sampling (spores/m3) | |
|
| |
| Indoor total | 501 ± 48 |
| Outdoor total | 3960 ± 467 |
Values are the count (percent) or mean ± standard deviation. Geometric means are reported for mold air samples.
Relationship of environmental allergen concentrations to allergen sensitization.
| Allergen | Concentrationa |
| Sensitivityb |
|
|---|---|---|---|---|
| Cockroach | Above median | 37 | 47% | 0.71 |
| Below median | 144 | 52% | ||
| dust mite | Above median | 63 | 60% | 0.17 |
| Below median | 118 | 71% | ||
| mouse | Above median | 81 | 36% | 0.15 |
| Below median | 100 | 25% | ||
|
| Above median | 90 | 58% | 0.32 |
| Below median | 91 | 49% | ||
| Cat | Yes | 16 | 63% | 0.04 |
| No | 166 | 33% | ||
| dog | Yes | 46 | 33% | 0.58 |
| No | 136 | 27% | ||
| indoor mold | Above median | 90 | 49% | 0.55 |
| Below median | 92 | 54% | ||
| outdoor mold | Above median | 91 | 54% | 0.55 |
| Below median | 91 | 49% | ||
| endotoxin | Above median | 69 | 51% | 0.81 |
| Below median | 71 | 55% | ||
|
| Above median | 54 | 48% | 0.29 |
| Below median | 55 | 60% |
aMedian concentrations: cockroach—0.2 U/g (lower limit of detection), dust mite—0.1 μg/g (LLOD), mouse—0.03 μg/g (LLOD), Alternaria—13.7 μg/g (LLOD), indoor mold—514 spores/m3, outdoor mold—3840 spores/m3, endotoxin—12 EU/mg, β-Glucan—0.4 μg/g. Cat and dog exposure were determined via a yes/no questionnaire item.
bFor indoor allergens (cockroach, dust mite, mouse, Alternaria, cat, and dog), sensitivity is indicated by a positive skin test to the given allergen (wheal at least 3 mm greater than the negative control). For mold, endotoxin, and β-Glucan, sensitivity is indicated by 4 or more positive skin tests out of 14 mold skin tests measured.
Relationship among asthma morbidity, dust allergen sensitivity, and dust allergen concentration.
| Outcomea | Concentrationb | Sensitivityc | Allergen | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cockroach |
| Dust mite |
| Mouse |
|
|
| |||
|
| Above median | Positive | 17 | 37 | 29 | 51 | ||||
| Negative | 19 | 25 | 51 | 37 | ||||||
| Below median | Positive | 75 | 83 | 25 | 45 | |||||
| Negative | 68 | 34 | 74 | 46 | ||||||
|
| ||||||||||
| Maximum symptom days | Above median | Positive | 8.24 | 7.38 | 7.14 | 7.82 | 0.16 | |||
| Negative | 6.42 | 0.37 | 6.80 | 0.44 | 6.33 | 0.56 | 6.78 | |||
| Below median | Positive | 6.89 | 6.72 | 5.60 | 5.71 | |||||
| Negative | 6.03 | 5.53 | 7.01 | 6.13 | ||||||
|
| ||||||||||
| Daytime symptoms | Above median | Positive | 5.82 | 5.89 | 5.34 | 6.35 | ||||
| Negative | 5.42 | 0.98 | 5.40 | 0.57 | 5.22 | 0.96 | 5.22 | 0.34 | ||
| Below median | Positive | 5.37 | 5.55 | 5.16 | 4.80 | |||||
| Negative | 5.29 | 4.44 | 5.61 | 5.04 | ||||||
|
| ||||||||||
| Night symptoms | Above median | Positive | 2.94 | 3.62 | 4.86 | 4.25 | ||||
| Negative | 2.79 | 0.33 | 2.48 | 0.51 | 3.06 | 0.19 | 2.30 | 0.18 | ||
| Below median | Positive | 3.99 | 3.64 | 3.00 | 3.11 | |||||
| Negative | 2.78 | 2.74 | 2.96 | 3.24 | ||||||
|
| ||||||||||
| Slow play | Above median | Positive | 6.18 | 3.81 | 4.34 | 3.84 | ||||
| Negative | 2.89 | 0.01 | 2.88 | 0.39 | 2.63 | 0.16 | 2.92 | 0.54 | ||
| Below median | Positive | 3.13 | 3.34 | 2.28 | 2.98 | |||||
| Negative | 2.54 | 2.29 | 3.39 | 2.83 | ||||||
|
| ||||||||||
| Caretaker changed plans | Above median | Positive | 1.53 | 0.81 | 1.34 | 1.12 | ||||
| Negative | 0.95 | 0.33 | 0.80 | 0.97 | 0.98 | 0.21 | 0.43 | 0.27 | ||
| Below median | Positive | 0.71 | 0.95 | 0.40 | 1.00 | |||||
| Negative | 0.93 | 0.91 | 0.82 | 0.91 | ||||||
aOutcome units are “number of days in the past 2 weeks.” P values test for an interaction between allergen sensitivity and concentration for the given outcome.
bMedian concentrations: cockroach—0.2 U/g (lower limit of detection), dust mite—0.1 μg/g (LLOD), mouse—0.03 μg/g (LLOD), Alternaria—13.7 μg/g (LLOD).
cSkin test wheal was at least 3 mm greater than the negative control; allergen sensitivity corresponds to dust allergen exposure (e.g., cockroach allergen sensitivity and concentration).
Relationship among asthma morbidity, mold sensitivity and airborne mold, endotoxin, or glucan concentrations.
| Outcomea | Concentrationb | Sensitivityc | Allergen | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Indoor mold |
| Outdoor mold |
| Endotoxin |
|
|
| |||
|
| Above median | Positive | 44 | 49 | 35 | 26 | ||||
| Negative | 46 | 41 | 33 | 28 | ||||||
| Below median | Positive | 49 | 44 | 39 | 33 | |||||
| Negative | 41 | 46 | 32 | 22 | ||||||
|
| ||||||||||
| Maximum symptom days | Above median | Positive | 5.39 | 6.20 | 7.14 | 6.38 | ||||
| Negative | 5.12 | <0.01 | 6.63 | 0.54 | 7.21 | 0.75 | 6.50 | 0.96 | ||
| Below median | Positive | 8.10 | 7.50 | 7.62 | 7.00 | |||||
| Negative | 7.85 | 6.20 | 6.31 | 6.45 | ||||||
|
| ||||||||||
| Daytime symptoms | Above median | Positive | 4.02 | 5.22 | 6.11 | 5.92 | ||||
| Negative | 4.07 | <0.01 | 5.32 | 0.91 | 5.55 | 0.97 | 4.93 | 0.89 | ||
| Below median | Positive | 6.82 | 5.80 | 6.03 | 5.52 | |||||
| Negative | 6.51 | 5.13 | 5.91 | 5.41 | ||||||
|
| ||||||||||
| Night symptoms | Above median | Positive | 3.05 | 3.51 | 3.63 | 4.15 | ||||
| Negative | 2.15 | 0.06 | 2.98 | 0.33 | 2.82 | 0.50 | 2.75 | 0.43 | ||
| Below median | Positive | 4.47 | 4.11 | 4.38 | 3.42 | |||||
| Negative | 3.44 | 2.57 | 3.38 | 2.36 | ||||||
|
| ||||||||||
| Slow play | Above median | Positive | 2.82 | 3.04 | 3.37 | 2.77 | ||||
| Negative | 1.98 | 0.03 | 2.54 | 0.23 | 3.30 | 0.17 | 2.61 | 0.97 | ||
| Below median | Positive | 4.24 | 4.16 | 3.92 | 2.91 | |||||
| Negative | 3.54 | 2.87 | 1.94 | 3.05 | ||||||
|
| ||||||||||
| Caretaker changed | Above median | Positive | 0.70 | 1.00 | 1.20 | 1.23 | ||||
| Negative | 0.41 | 0.05 | 0.80 | 0.90 | 0.67 | 0.44 | 0.50 | 0.42 | ||
| Below median | Positive | 1.22 | 1.00 | 0.72 | 0.79 | |||||
| Negative | 1.22 | 0.78 | 1.13 | 0.95 | ||||||
aUnits are “number of days in the past 2 weeks.” P values test for an interaction between allergen sensitivity and concentration for the given outcome.
bMedian concentrations: indoor mold—514 spores/m3, outdoor mold—3840 spores/m3, endotoxin—12 EU/mg, β-Glucan—0.4 μg/g.
cFour or more skin test wheals that are at least 3 mm greater than the negative control out of 14 mold skin tests measured.
Relationship between airborne mold levels and asthma morbidity by study visit.
| Home evaluation | Symptom assessment | Number of maximum symptom days |
| ||
|---|---|---|---|---|---|
| Airborne mold > median | Airborne mold ≤ median | Diff | |||
| Baseline | Baseline | 5.2 | 8.0 | −2.8 | <0.001 |
| 6 months | 3.2 | 3.5 | −0.3 | 0.65 | |
| 12 months | 3.4 | 3.8 | −0.4 | 0.56 | |
| 6 months | 6 months | 3.1 | 3.0 | −0.1 | 0.80 |
| 12 months | 3.6 | 3.6 | −0.0 | 0.94 | |
| 12 months | 12 months | 3.4 | 3.5 | −0.1 | 0.89 |
Values are unadjusted for potential confounding variables (e.g., parish, season, income, race, age, and sex). Followup MSD were measured at 6 or 12 months and airborne mold levels were measured at baseline 6 or 12 months.